Insider · CIK 0001392029
Todd C Davis
Files at LGND (LIGAND PHARMACEUTICALS INC), PVLA (PALVELLA THERAPEUTICS, INC.), PTHS (Pelthos Therapeutics Inc.). First filing May 13, 2025, latest May 13, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LGND: LIGAND PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | LIGAND PHARMACEUTICALS INC | $1.0M 9,510 shares | +6% | +8% from low-20% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | PTHS Pelthos Therapeutics Inc. | AGrant or award Restricted Stock Unitsderivative | +19,108 | - | - | 36,969 | Jul 7, 2025 |
| Jul 2, 2025 | PTHS Pelthos Therapeutics Inc. | AGrant or award Stock Optionderivative | +58,230 | - | - | 58,230 | Jul 7, 2025 |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | CConversion Common Stockindirect: By Ligand Pharmaceuticals Incorporated | +1,500,000 | $10.00 | $15M | 1,500,000 | Jul 3, 2025 |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | CConversion Series A Convertible Preferred Stockderivativeindirect: See footnote | -15,000 | $0.00 | $0 | 3,000 | Jul 3, 2025 |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | JOther Series A Convertible Preferred Stockderivativeindirect: See footnote | +31,279 | - | - | 3,127,868 | Jul 3, 2025 |
| Jun 30, 2025 | LGND LIGAND PHARMACEUTICALS INC | JOther Common Stock | +233 | $91.08 | $21k | 161,467 | Jul 2, 2025 |
| Jun 10, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +12,350 | $0.00 | $0 | 12,350 | Jun 11, 2025 |
| May 9, 2025 | LGND LIGAND PHARMACEUTICALS INC | POpen-market purchase Common Stock | +1,680 | $104.57 | $176k | 153,404 | May 13, 2025 |
| May 9, 2025 | LGND LIGAND PHARMACEUTICALS INC | POpen-market purchase Common Stock | +2,307 | $104.53 | $241k | 155,711 | May 13, 2025 |
| May 9, 2025 | LGND LIGAND PHARMACEUTICALS INC | POpen-market purchase Common Stock | +5,523 | $105.67 | $584k | 161,234 | May 13, 2025 |
| Mar 4, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +21,382 | $0.00 | $0 | 151,724 | Mar 6, 2025 |
| Mar 4, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +93,476 | $0.00 | $0 | 93,476 | Mar 6, 2025 |
| Feb 14, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +20,784 | $0.00 | $0 | 143,794 | Feb 19, 2025 |
| Feb 14, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -6,966 | $120.00 | $836k | 136,828 | Feb 19, 2025 |
| Feb 15, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -2,231 | $120.00 | $268k | 134,597 | Feb 19, 2025 |
| Feb 15, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -4,255 | $120.00 | $511k | 130,342 | Feb 19, 2025 |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +24,700 | $0.00 | $0 | 24,700 | Dec 17, 2024 |
| Nov 13, 2024 | PTHS Pelthos Therapeutics Inc. | AGrant or award Restricted Stock Unitsderivative | +49,605 | - | - | 263,306 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.